Clinical Characteristics and Treatment of Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients Dr Ishan Kataria3 July 2022 8:00 PM ISTDupilumab has been approved by the Food and Drug Administration (FDA) to treat adults with moderate-to-severe atopic dermatitis (AD) that is...
FDA approves dupilumab for treatment of atopic dermatitis in pediatric patients Dr. Kamal Kant Kohli10 Jun 2022 9:00 AM ISTTARRYTOWN, N.Y. and PARIS: The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for children aged 6 months to 5 years with...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
Upadacitinib most effective oral JAK inhibitor for treating atopic dermatitis, study claims Medha Baranwal7 Jun 2022 11:00 AM ISTUSA: Janus kinase (JAK) inhibitors are an effective treatment for atopic dermatitis (AD) patients, according to results from a new systematic review....
Bleach baths may benefit patients with mild to severe atopic dermatitis Dr. Shravani Dali11 May 2022 11:00 AM ISTBleach baths may help patients with mild to severe atopic dermatitis, according to a recent study published in the Annals of Allergy, Asthma &...
Antioxidants safe and effective treatment option for atopic dermatitis patients Medha Baranwal9 May 2022 8:00 PM ISTChina: Antioxidants alone or when combined with oral vitamin D and topical vitamin B12 may be a safe and effective treatment for atopic dermatitis...
Which systemic therapies good at improving index scores in moderate-to-severe atopic dermatitis? Medical Dialogues Editorial Team1 April 2022 8:30 PM ISTA new meta analysis showed that Upadacitinib, 30 mg daily, and abrocitinib, 200 mg daily, were linked with somewhat better ratings than dupilumab,...
IQVIA gets CDSCO panel nod to conduct study of ASLAN004 for atopic dermatitis Dr. Divya Colin20 March 2022 10:15 AM ISTNew Delhi: Drug maker IQVIA has got approval from the Central Drugs Standard Control Organization (CDSCO) to conduct a Phase IIb clinical trial of...
Oral difelikefalin effective in reducing atopic dermatitis- associated pruritus: Study Medha Baranwal17 March 2022 9:00 AM ISTUSA: In a recent study, the researchers observed a rapid, significant anti-pruritic effect of difelikefalin (DFK) in an atopic dermatitis (AD) mouse...
Common Dermatological Conditions That Present Differently in Coloured Children MD Bureau10 March 2022 9:00 AM ISTPediatric patients with skin of colour, which refers to individuals with Fitzpatrick skin types III through VI, comprising many racial and ethnic...
Sanofi Dupixent under USFDA priority review for kids with atopic dermatitis Ruchika Sharma11 Feb 2022 12:23 PM ISTParis: Sanofi has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the supplemental Biologics...
Atopic dermatitis associated to affect mental health Dr. Nandita Mohan3 Feb 2022 4:55 PM ISTAtopic dermatitis affects quality of life greatly, the flares on the skin is much painful and irritating that needs management. Atopic dermatitis is...
